Central Nervous System Neoplasm — Trials

Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,060 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 148 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04337177	Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors	active not recruiting	Phase 1	20	Valent Technologies, LLCINDUSTRY	1	Jul 30, 2026	clinicaltrials
NCT04555577	Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma	active not recruiting	Phase 1	29	M.D. Anderson Cancer CenterOTHER	1	Jul 30, 2026